September 12, 2025Thoracic CancerOpen Access

Clinical Significance of Time‐to‐Surgery and COVID‐19 Pandemic in Surgically Treated Non‐Small Cell Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis shows that delayed time-to-surgery worsens survival rates in NSCLC patients, indicating COVID-19 pandemic effects.

Patients with time-to-surgery ≥ 2 months had significantly impaired overall survival compared to those with shorter wait times.
The study found that during the COVID-19 pandemic, time to surgery increased by a median of 12 days, significantly delaying treatment.
Survival analysis using Kaplan-Meier plots revealed important differences driven by time-to-surgery, disease stage, and age.
COVID-19 waves did not significantly alter time-to-surgery, despite delays observed during the pandemic period.

Ghimessy et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark